Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.02B |
| 2 |
Apple
AAPL
|
+$837M |
| 3 |
Amazon
AMZN
|
+$811M |
| 4 |
Kenvue
KVUE
|
+$761M |
| 5 |
Blackstone
BX
|
+$581M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$438M |
| 2 |
Texas Instruments
TXN
|
+$235M |
| 3 |
Pfizer
PFE
|
+$205M |
| 4 |
LSI
Life Storage, Inc.
LSI
|
+$202M |
| 5 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.7% |
| 2 | Healthcare | 13.07% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
CRISPR Therapeutics
CRSP
$4.73B
| $38.6M | ﹤0.01% |
849,938
+15,331
| +2% | +$792K |
|
1402
ICU Medical
ICUI
$4.21B
| $38.5M | ﹤0.01% |
323,832
+7,395
| +2% | +$1.1M |
|
1403
Dana Inc
DAN
$2.9B
| $38.5M | ﹤0.01% |
2,622,270
+90,970
| +4% | +$1.52M |
|
1404
Edgewell Personal Care
EPC
$1.25B
| $38.5M | ﹤0.01% |
1,040,785
+37,951
| +4% | +$1.47M |
|
1405
Carter's
CRI
$1.42B
| $38.5M | ﹤0.01% |
556,113
+7,896
| +1% | +$564K |
|
|
MRTX
1406
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $38.4M | ﹤0.01% |
881,226
+116,743
| +15% | +$4.17M |
|
1407
Southern Copper
SCCO
$143B
| $38.2M | ﹤0.01% |
549,868
+16,263
| +3% | +$1.19M |
|
1408
Diamondrock Hospitality Co
DRH
$2.71B
| $38.2M | ﹤0.01% |
4,753,973
+159,501
| +3% | +$1.28M |
|
1409
Kemper
KMPR
$1.67B
| $38.1M | ﹤0.01% |
907,226
-17,943
| -2% | -$851K |
|
1410
Skywest
SKYW
$4.24B
| $38.1M | ﹤0.01% |
907,527
-33,943
| -4% | -$1.42M |
|
1411
Crinetics Pharmaceuticals
CRNX
$8.84B
| $37.8M | ﹤0.01% |
1,269,674
+282,184
| +29% | +$5.81M |
|
1412
Greif
GEF
$4.92B
| $37.7M | ﹤0.01% |
564,299
+15,905
| +3% | +$1.13M |
|
1413
Gentherm
THRM
$1.25B
| $37.7M | ﹤0.01% |
694,795
+29,267
| +4% | +$1.7M |
|
1414
Samsara
IOT
$21.7B
| $37.6M | ﹤0.01% |
1,489,332
+308,830
| +26% | +$8.19M |
|
1415
Green Plains
GPRE
$1.18B
| $37.6M | ﹤0.01% |
1,247,494
+45,366
| +4% | +$1.49M |
|
|
CVSA
1416
Covista Inc
CVSA
$4.25B
| $37.5M | ﹤0.01% |
876,139
-5,317
| -0.6% | -$225K |
|
1417
Stride
LRN
$3.41B
| $37.5M | ﹤0.01% |
832,841
+26,037
| +3% | +$1.06M |
|
1418
Pebblebrook Hotel Trust
PEB
$2.15B
| $37.3M | ﹤0.01% |
2,742,459
+58,525
| +2% | +$839K |
|
1419
Amphastar Pharmaceuticals
AMPH
$879M
| $37.2M | ﹤0.01% |
809,626
+29,367
| +4% | +$1.6M |
|
|
HTO
1420
H2O America
HTO
$2.57B
| $37.2M | ﹤0.01% |
619,359
+41,280
| +7% | +$2.77M |
|
1421
WIX.com
WIX
$2.3B
| $37.2M | ﹤0.01% |
406,630
+8,489
| +2% | +$758K |
|
1422
Q2 Holdings
QTWO
$3.8B
| $37.2M | ﹤0.01% |
1,152,881
+35,889
| +3% | +$1.19M |
|
1423
Riot Platforms
RIOT
$7.63B
| $37.2M | ﹤0.01% |
3,984,264
+346,915
| +10% | +$4.78M |
|
|
B
1424
DELISTED
Barnes Group Inc.
B
| $37.1M | ﹤0.01% |
1,091,371
+42,544
| +4% | +$1.65M |
|
1425
Vestis
VSTS
$1.91B
| $37.1M | ﹤0.01% |
+1,922,192
| New | +$37.2M |
|
Similar funds
Geode Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Geode Capital Management held 4,905 positions worth $840B, down 1.3% from $851B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Geode Capital Management's Q3 2023 filing shows 147 new, 3,717 increased, 626 reduced and 142 closed positions. Its largest new stake was Kenvue: 32,873,626 shares worth $659M. The largest sale was Johnson & Johnson, an estimated $438M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q3 2023 buy was Kenvue: 32,873,626 shares worth $659M.
- Geode Capital Management added most to Microsoft in Q3 2023, an estimated $1.02B increase.
- Geode Capital Management's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $438M.
- Geode Capital Management fully exited Life Storage, Inc. in Q3 2023, selling an estimated $202M.
- Geode Capital Management's ten largest holdings make up 26% of its $840B portfolio in Q3 2023.
- Geode Capital Management opened 147 new positions and closed 142 in Q3 2023.
- Geode Capital Management's portfolio value fell 1.3% quarter-over-quarter to $840B.
Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.